New statewide collaboration modernizes the Housing Choice Voucher leasing process and accelerates the time it takes for families to secure safe, affordable homes AffordableHousing.com, in partnership with the Delaware Housing Access Association (DHAA), today announced the launch of a statewide electronic Request for Tenancy Approval (RFTA) system designed to streamline and modernize the Housing Choice […]

The award honors medical society executives who have made outstanding contributions to the profession of medicine by improving medical practice, education, or public health. The American Medical Association (AMA) has awarded Susan Benigas, chief executive officer of the American College of Lifestyle Medicine (ACLM), its 2025 Medical Executive Meritorious Achievement Award for her exceptional leadership

Keeping loved ones safe as families gather for the holidays As loved ones prepare to gather and give thanks, the National Safety Councilis focused on ensuring every traveler reaches their destination safely. Thanksgiving roadway safety continues to improve, with NSC projecting 439 traffic fatalities during the holiday period – down from 502 last year. However,

Pomerantz LLP is investigating claims on behalf of investors of Prelude Therapeutics Incorporated (“Prelude” or the “Company”) (NASDAQ: PRLD). Such investors are advised to contact Danielle Peyton atnewaction@pomlaw.comor 646-581-9980, ext.7980. https://mma.prnewswire.com/media/2287619/Pomerantz_V3_Logo.jpg The investigation concerns whetherPreludeand certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information

Pomerantz LLP is investigating claims on behalf of investors of Simulations Plus, Inc. (“Simulations Plus” or the “Company”) (NASDAQ: SLP).Such investors are advised to contact Danielle Peyton at newaction@pomlaw.comor 646-581-9980, ext.7980. https://mma.prnewswire.com/media/2287619/Pomerantz_V3_Logo.jpg The investigation concerns whether Simulations Plus and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.

Pomerantz LLP is investigating claims on behalf of investors ofBellRing Brands, Inc. (“BellRing” or the “Company”) (NYSE: BRBR).Such investors are advised to contact Danielle Peyton at newaction@pomlaw.comor 646-581-9980, ext.7980. https://mma.prnewswire.com/media/2287619/Pomerantz_V3_Logo.jpg The investigation concerns whether BellRing and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for

Pomerantz LLP is investigating claims on behalf of investors of Trex Company, Inc. (“Trex” or the “Company”) (NYSE: TREX).Such investors are advised to contact Danielle Peyton at newaction@pomlaw.comor 646-581-9980, ext. 7980. https://mma.prnewswire.com/media/2287619/Pomerantz_V3_Logo.jpg The investigation concerns whether Trex and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click

Pomerantz LLP is investigating claims on behalf of investors of Alaska Air Group, Inc. (“Alaska Air” or the “Company”) (NYSE: ALK).Such investors are advised to contact Danielle Peyton at newaction@pomlaw.comor 646-581-9980, ext.7980. https://mma.prnewswire.com/media/2287619/Pomerantz_V3_Logo.jpg The investigation concerns whether Alaska Air and certain of its officers and/or directors have engaged in securities fraud or other unlawful business

Pomerantz LLP is investigating claims on behalf of investors of CoreWeave, Inc. (“CoreWeave” or the “Company”) (NASDAQ: CRWV).Such investors are advised to contact Danielle Peyton at newaction@pomlaw.comor 646-581-9980, ext.7980. https://mma.prnewswire.com/media/2287619/Pomerantz_V3_Logo.jpg The investigation concerns whether CoreWeave and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for

Pomerantz LLP is investigating claims on behalf of investors of Outset Medical, Inc. (“Outset Medical” or the “Company”) (NASDAQ: OM).Such investors are advised to contact Danielle Peyton at newaction@pomlaw.comor 646-581-9980, ext.7980. https://mma.prnewswire.com/media/2287619/Pomerantz_V3_Logo.jpg The investigation concerns whether Outset Medical and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.